Real Strategy Is Returning

Lately, I have been thinking about a simple idea; strategy is not becoming something new. It is returning to something older and more demanding.

Not the deck. Not the framework. Not the performance of preparedness. The real thing. Strategy is understanding what’s really happening, deciding where and how to act, and organizing effort in a way that can survive reality.

That shift matters in every category. In healthcare, it matters even more.

This is a business that exposes empty strategy quickly. You can polish the language, sharpen the narrative, and make the process look rigorous, but if the work is not grounded in the actual conditions surrounding patients, clinicians, brands, and behavior, the gap shows fast. In this category, you do not get much credit for sounding strategic. You get credit for understanding what is actually going on and helping people move through it.

That’s part of why I built Princeton10 the way I did.

I did not start this agency because the market needed another healthcare firm saying roughly the same things in slightly different language. I built it because I believed healthcare communications needed a different strategic center. One that was closer to the real conditions around health. One that understood that healthcare is never just the prescription moment. It is culture. It is behavior. It is systems. It is trust. It is lived experience. And if you separate the work from those things, you may still produce communications, but you are much less likely to produce communications that matter.

So, when people ask where strategy needs to go, my view is pretty direct: we have been building toward that place all along.

From the beginning, we believed strategy had to be bigger than a role and more useful than a deliverable. It had to function as a philosophy and a practice. It had to help teams see clearly, choose deliberately, and act coherently. That is very different from using strategy to bless work after the fact or package assumptions in language that feels impressive in a room. It means strategy has to stay close to reality, and close to consequence.

It means owning the context, not just the assignment. If strategy starts when the brief arrives, it is already late. You have to know what is shifting beneath the work before someone asks for a point of view. You have to read beyond pharma. You have to watch culture. You have to understand adjacent categories. You have to see tensions as they emerge, not after they harden into obvious trends. Otherwise strategy becomes recycled messaging with better formatting.

It also means intervening earlier. Some of the most important strategy work does not happen in a workshop or a reveal. It happens when someone asks the clarifying question before discovery starts. It happens when someone sees that the work is drifting away from the real challenge and redirects it before momentum takes over. It happens when complexity is simplified before it becomes noise. That kind of influence is quieter than what this industry has traditionally celebrated, but it is often far more valuable. It is steady influence that prevents volatility instead of reacting to it later.

And it means thinking in systems, not assets. Healthcare is too interconnected to be understood piece by piece. Brand, content, social, CRM, experience, audience behavior, journey architecture, and AI-driven engagement systems all affect one another. Strategy has to be able to see the pattern, not just the part. That is why the strategist we believe in is not just a brief writer or a deck assembler. It is a sense-maker, a pattern-recognizer, a system designer, and a directional partner.

Clients do not just need sharper messaging. They need help making sense of more inputs, more ambiguity, more channels, more pressure, and more overlap between what used to be separate domains. They need someone who can connect business ambition to human behavior, scientific credibility to lived experience, and category expertise to what is happening in the broader world. In healthcare especially, you cannot afford to think too narrowly. Healthcare is culture, whether the industry is comfortable admitting that or not. You cannot separate the science from the system, or the prescription from the person, or the work from the world it enters.

That is one of the reasons this way of thinking also gives us permission to speak more credibly to healthcare-adjacent categories. Not because we are trying to be everything to everyone, and not because we have suddenly abandoned the seriousness of RX communications. Quite the opposite. It is because we understand that health is bigger than the walls of traditional pharma marketing, and that the discipline required to navigate healthcare well can be brought to a broader set of problems, as long as you do it with the right level of care, judgment, and respect for the stakes. The same acumen required to navigate Rx communications--evidence, behavior, trust, regulation, culture, and consequence--translates valuably across a wider health landscape.

This is not a sudden pivot. It is a clearer expression of what we were trying to build from the start. More outside-in thinking. More active interpretation. More strategic guidance before the brief. More ability to connect signals across categories and systems. More willingness to stay in the harder, more useful work of helping clients see what is actually true and decide what to do about it.

That, to me, is where strategy is going. Or maybe more accurately, that is where it is returning.

And if that is the future, then we are not trying to catch up to it. We are trying to help lead it.